[{"address1": "100 Campus Drive", "address2": "Suite 102", "city": "Florham Park", "state": "NJ", "zip": "07932", "country": "United States", "phone": "877 742 8466", "website": "https://www.phathompharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Phathom Pharmaceuticals, Inc., biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada for an investigational potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. The company was incorporated in 2018 and is headquartered in Florham Park, New Jersey.", "fullTimeEmployees": 452, "companyOfficers": [{"maxAge": 1, "name": "Ms. Terrie J. Curran", "age": 55, "title": "President, CEO & Director", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 1222527, "exercisedValue": 0, "unexercisedValue": 1865398}, {"maxAge": 1, "name": "Mr. David A. Socks", "age": 49, "title": "Co-Founder & Director", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 54167, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Azmi  Nabulsi M.D., M.P.H.", "age": 65, "title": "Co-Founder & COO", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 888897, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Molly  Henderson CPA, MBA", "age": 53, "title": "Chief Financial & Business Officer", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 777763, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Aditya  Kohli Ph.D.", "age": 36, "title": "Co-Founder", "yearBorn": 1988, "fiscalYear": 2023, "totalPay": 319647, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul  Cocja", "title": "Chief People Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tom  Harris", "title": "Chief Development Sciences Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Eckhard  Leifke M.D., Ph.D.", "title": "Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Martin J. Gilligan", "title": "Chief Commercial Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 8, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1735689600, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 6.96, "open": 6.98, "dayLow": 6.78, "dayHigh": 7.05, "regularMarketPreviousClose": 6.96, "regularMarketOpen": 6.98, "regularMarketDayLow": 6.78, "regularMarketDayHigh": 7.05, "beta": 0.718, "forwardPE": -1.9536842, "volume": 734283, "regularMarketVolume": 734283, "averageVolume": 1290863, "averageVolume10days": 855870, "averageDailyVolume10Day": 855870, "bid": 6.93, "ask": 6.97, "bidSize": 100, "askSize": 100, "marketCap": 475906720, "fiftyTwoWeekLow": 6.065, "fiftyTwoWeekHigh": 19.71, "priceToSalesTrailing12Months": 18.115976, "fiftyDayAverage": 9.113, "twoHundredDayAverage": 11.968825, "currency": "USD", "enterpriseValue": 660220416, "floatShares": 55750797, "sharesOutstanding": 68377400, "sharesShort": 14954493, "sharesShortPriorMonth": 14054465, "sharesShortPreviousMonthDate": 1732838400, "dateShortInterest": 1735603200, "sharesPercentSharesOut": 0.2187, "heldPercentInsiders": 0.07725, "heldPercentInstitutions": 1.09164, "shortRatio": 14.87, "shortPercentOfFloat": 0.3087, "impliedSharesOutstanding": 68377400, "bookValue": -2.739, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -339444992, "trailingEps": -5.74, "forwardEps": -4.0, "enterpriseToRevenue": 25.132, "enterpriseToEbitda": -2.299, "52WeekChange": -0.11337578, "SandP52WeekChange": 0.23631513, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "PHAT", "underlyingSymbol": "PHAT", "shortName": "Phathom Pharmaceuticals, Inc.", "longName": "Phathom Pharmaceuticals, Inc.", "firstTradeDateEpochUtc": 1572010200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "4c8c1fb1-8c10-35f8-ba4b-c2b6b83aa924", "messageBoardId": "finmb_613615658", "gmtOffSetMilliseconds": -18000000, "currentPrice": 6.96, "targetHighPrice": 28.0, "targetLowPrice": 17.0, "targetMeanPrice": 24.85714, "targetMedianPrice": 28.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 334678016, "totalCashPerShare": 4.895, "ebitda": -287137984, "totalDebt": 518992000, "quickRatio": 5.449, "currentRatio": 5.726, "totalRevenue": 26270000, "revenuePerShare": 0.44, "returnOnAssets": -0.57674, "grossProfits": 21945000, "freeCashflow": -179773248, "operatingCashflow": -247111008, "grossMargins": 0.83536005, "operatingMargins": -4.3295, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-01-18"}]